Overview * TJX Q3 FY26 revenue grows 7% yr/yr, beating analyst expectations * Q3 diluted EPS rises 12% to $1.28, exceeding company plan * Company returned $1.1 bln to shareholders via buybacks and dividends in Q3 Outlook * Company expects Q4 comp sales to rise 2% to 3% * TJX raises full-year EPS outlook to $4.63-$4.66 * Company plans $2.5...

07:37 AM EST, 11/19/2025 (MT Newswires) -- Merck ( MRK ) said Wednesday the pivotal phase 3 trial of its investigational regimen of doravirine/islatravir in treatment-naive adults with HIV-1 infection met its success criterion of primary efficacy. Trial topline results showed the non-inferiority of the drug and a comparable safety profile to once-daily oral bictegravir/emtricitabine/tenofovir alafenamide, Merck ( MRK )...

07:38 AM EST, 11/19/2025 (MT Newswires) -- Dana (DAN) and Allison Transmission ( ALSN ) said Wednesday they have received all required regulatory approvals for the previously announced sale of Dana's off-highway business to Allison. The transaction is expected to close at or near the year-end, the companies said. The transaction has enabled Dana to return $600 million to shareholders...

(Reuters) -TJX Cos ( TJX ) raised annual profit forecast on Wednesday, anticipating that broad sourcing strategy and seasonal inventory will attract bargain-hunting shoppers to its off-price stores. Shares of the company rose about 3% in premarket trading. They have risen nearly 21% so far this year. The Framingham, Massachusetts-based company has capitalized on a seasonal shift from late-summer to...